Epalrestat
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Epalrestat Product Information
Epalrestat is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Epalrestat. The product is supplied by Clearsynth under CAT No. CS-O-11636.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Epalrestat
CAS No.
82159-09-9
CAT No.
CS-O-11636
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C15H13NO3S2
Molecular Weight
319.40
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Epalrestat is supplied with detailed characterization data compliant with regulatory guideline. Epalrestat can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Epalrestat.
Overview
An aldose reductase inhibitor. It is used in treatment of diabetic neuropathy.
Synonyms
Epalrestat
Application Notes
An aldose reductase inhibitor. It is used in treatment of diabetic neuropathy.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.